Nunatak Biotech
PrivateLast Round
Accelerator
Jun 19, 2025
Total Funding Raised
$107,000
Company Overview
Nunatak Biotech operates in Healthcare & Life Sciences and is based in Buenos Aires. Its latest recorded funding round was an Accelerator round in June 2025.
Nunatak Biotech is an AgTech company that develops microbial bioinputs derived from extremophile microorganisms to improve crop resilience, soil health, and agricultural productivity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nunatak Biotech Comparables
Compare Nunatak Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Symbiomics | 84% | |
| Puna Bio | 83% | |
| endophyte Inc. | 80% |
For institutional investors. Book with your work email.
Nunatak Biotech Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nunatak Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SVG Ventures|THRIVE | Accelerator |
| Eatable Adventures | Accelerator |
| German Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 35% MoM.
- Apr 17, 2026
Monthly visitors grew 192% MoM from 150 to 438.
For institutional investors. Book with your work email.
Nunatak Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nunatak Biotech's valuation, stock price, and market status.
Is Nunatak Biotech a public or private company?
Nunatak Biotech is a private company.
What is the current stock price of Nunatak Biotech?
Nunatak Biotech is a private company, so its shares have no public market price. Caplight tracks Nunatak Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nunatak Biotech worth (valuation)?
Valuation information for Nunatak Biotech is not publicly available.
Can I buy Nunatak Biotech stock?
Nunatak Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nunatak Biotech's last funding round?
Nunatak Biotech's most recent funding round was Accelerator on June 19, 2025.
Who are the main investors in Nunatak Biotech?
Key investors in Nunatak Biotech include Eatable Adventures.
Will Nunatak Biotech IPO soon?
No public IPO plans have been announced for Nunatak Biotech.
How can I track Nunatak Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Nunatak Biotech's shares on secondary markets.